Ignite Creation Date:
2025-12-24 @ 3:27 PM
Ignite Modification Date:
2025-12-26 @ 3:07 PM
Study NCT ID:
NCT05020392
Status:
UNKNOWN
Last Update Posted:
2023-07-25
First Post:
2021-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma
Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-13
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10-13
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-19
First Submit QC Date:
None
Study First Post Date:
2021-08-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-23
Last Update Post Date:
2023-07-25
Last Update Post Date Type:
ACTUAL